Lactococcus lactis KF140 Reduces Dietary Absorption of N-epsilon-(Carboxymethyl)lysine in Rats and Humans via beta-Galactosidase Activityopen access
- Authors
- Park, Ho-Young; Lee, Hye-Bin; Lee, So-Young; Oh, Mi-Jin; Ha, Sang Keun; Do, Eunju; Lee, Hyun Hee L.; Hur, Jinyoung; Lee, Kwang-Won; Nam, Mi-Hyun; Park, Myoung Gyu; Kim, Yoonsook
- Issue Date
- 24-6월-2022
- Publisher
- FRONTIERS MEDIA SA
- Keywords
- Lactococcus lactis (L. lactis); advanced glycation end product (AGE); N-epsilon-(carboxymethyl)lysine (CML); beta-galactosidase; probiotic
- Citation
- FRONTIERS IN NUTRITION, v.9
- Indexed
- SCIE
SCOPUS
- Journal Title
- FRONTIERS IN NUTRITION
- Volume
- 9
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/142789
- DOI
- 10.3389/fnut.2022.916262
- ISSN
- 2296-861X
- Abstract
- Background and Aims: Excessive intake of advanced glycation end products (AGEs), which are formed in foods cooked at high temperatures for long periods of time, has negative health effects, such as inflammatory responses and oxidative stress. N-epsilon-(Carboxymethyl)lysine (CML) is one of the major dietary AGEs. Given their generally recognized as safe status and probiotic functionalities, lactic acid bacteria may be ideal supplements for blocking intestinal absorption of food toxicants. However, the protective effects of lactic acid bacteria against dietary AGEs have not been fully elucidated. Materials and Methods: We investigated the effect of treatment with Lactococcus lactis KF140 (LL-KF140), which was isolated from kimchi, on the levels and toxicokinetics of CML. The CML reduction efficacies of the Lactococcus lactis KF140 (LL-KF140), which was isolated from kimchi, were conducted by in vitro test for reducing CML concentration of the casein-lactose reaction product (CLRP) and in vivo test for reducing serum CML level of LL-KF140 administered rats at 2.0 x 10(8) CFU/kg for14 days. In addition, 12 volunteers consuming LL-KF140 at 2.0 x 10(9) CFU/1.5 g for 26 days were determined blood CML concentration and compared with that before intake a Parmesan cheese. Results: Administration of LL-KF140 reduced serum CML levels and hepatic CML absorption in rats that were fed a CML-enriched product. In a human trial, the intake of LL-KF140 prevented increases in the serum levels of CML and alanine aminotransferase after consumption of a CML-rich cheese. LL-KF140 was determined to presence in feces through metagenorne analysis. Furthermore, beta-galactosidase, one of the L. lactis-produced enzymes, inhibited the absorption of CML and reduced the levels of this AGE, which suggests an indirect inhibitory effect of LL-KF140. This study is the first to demonstrate that an L. lactis strain and its related enzyme contribute to the reduction of dietary absorption of CML.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Sciences and Biotechnology > Division of Food Bioscience and Technology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.